Arteriosclerosis coronary artery and Idiopathic retroperitoneal fibrosis

Summary:

Idiopathic retroperitoneal fibrosis is reported only by a few people with Arteriosclerosis coronary artery.

The study analyzes which people have Idiopathic retroperitoneal fibrosis with Arteriosclerosis coronary artery. It is created by eHealthMe based on 1 person who has Idiopathic retroperitoneal fibrosis and Arteriosclerosis coronary artery from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Feb, 07, 2023

1 person who has Arteriosclerosis Coronary Artery and Idiopathic Retroperitoneal Fibrosis is studied.


What is Arteriosclerosis coronary artery?

Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery) is found to be associated with 1,460 drugs and 852 conditions by eHealthMe.

What is Idiopathic retroperitoneal fibrosis?

Idiopathic retroperitoneal fibrosis (disorder that blocks the tubes (ureters) that carry urine) is found to be associated with 509 drugs and 368 conditions by eHealthMe.

Number of Idiopathic retroperitoneal fibrosis in Arteriosclerosis coronary artery reports submitted per year:

Would you have Idiopathic retroperitoneal fibrosis when you have Arteriosclerosis coronary artery?

Gender of people who have Arteriosclerosis Coronary Artery and experienced Idiopathic Retroperitoneal Fibrosis *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Arteriosclerosis Coronary Artery and experienced Idiopathic Retroperitoneal Fibrosis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common co-existing conditions for these people *:

  1. Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery): 1 person, 100.00%

Common symptoms for these people *:

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Idiopathic retroperitoneal fibrosis?

Check whether Idiopathic retroperitoneal fibrosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Idiopathic retroperitoneal fibrosis:

All the drugs that are associated with Idiopathic retroperitoneal fibrosis:

All the conditions that are associated with Idiopathic retroperitoneal fibrosis:

How the study uses the data?

The study is based on Idiopathic retroperitoneal fibrosis and Arteriosclerosis coronary artery, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: